8-K current report · filed Oct 27, 2026

ORTHOPEDIATRICS CORP (KIDS) 8-K Current Report: October 27, 2026

Item 7.01Item EX-99.1KIDS overview

Short answer

ORTHOPEDIATRICS CORP (KIDS) filed an 8-K current report with the SEC on October 27, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Upcoming investor and analyst presentations by OrthoPediatrics executives.

ORTHOPEDIATRICS CORP 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Upcoming investor and analyst presentations by OrthoPediatrics executives
  • Exhibit 99.1 contains presentation materials that may shape near-term investor expectations

Item EX-99.1 · Exhibit EX-99.1

  • 3Q26 revenue $72.7M, up 19%, with gross margin steady at 74%
  • Net loss narrowed to $5.9M from $11.8M, while diluted loss improved to $0.25 from $0.50
  • Adjusted EBITDA increased to $6.9M from $6.2M, supporting operating leverage despite continued investment
  • FY2026 guidance: revenue $270.0M to $273.0M, 14% to 16% growth, adjusted EBITDA approximately $25.0M
  • Balance sheet included $44.9M cash and investments versus $98.4M debt as of September 30, 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ORTHOPEDIATRICS CORP 8-K filings

Get the next KIDS 8-K as it lands

Follow KIDS for push alerts, or ask the research agent what this filing means.